Active, not recruitingPhase 3NCT07057037

Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases

Studying Anorectal malformation

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Inventera Inc.
Intervention: NEMO-103 Injection(drug)
Enrollment: 85 target
Eligibility: 19 years · All sexes
Timeline: 2025 – 2026

Study locations (8)

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Hospital, Seoul, Seoul Teugbyeolsi, South Korea
Yonsei University Health System, Severance Hospital, Seoul, Seoul Teugbyeolsi, South Korea
Konkuk University Medical Center, Seoul, Seoul Teugbyeolsi, South Korea
Gangnam Severance Hospital, Seoul, Seoul Teugbyeolsi, South Korea
The Catholic University of Korea Seoul ST. Mary's Hospital, Seoul, Seoul Teugbyeolsi, South Korea
Korea University Guro Hospital, Seoul, Seoul Teugbyeolsi, South Korea
Asan Medical Center, Seoul, Seoul Teugbyeolsi, South Korea

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07057037 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation →

← Back to all trials